Researchers Submit Patent Application, "Treatment Of Schizophrenia And Bipolar Disorder", for Approval (USPTO 20240263238).

This document is a patent application for a method of treating schizophrenia and bipolar disorder. The method involves identifying a specific sequence of a novel open reading frame (nORF) associated with these disorders and administering an inhibitor to reduce the expression of the nORF. The inhibitor can be a small molecule, polynucleotide, or polypeptide, and it can be delivered using a viral vector. Alternatively, the method also includes providing a protein encoded by the nORF to the subject to treat the disorders. The patent application provides detailed claims and descriptions of the methods. [Extracted from the article]